Skip to content

Ayurveda management of Cerebral Palsy

A Comparative Study of Matra Basti and Chaturbhadra Kalpa Basti along with Samvardhan Ghrita in management of Cerebral Palsy - CMCS-CP

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025956
Enrollment
30
Registered
2020-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G80- Cerebral palsy

Interventions

Intervention1: Group A- Matra Basti and Samvardhan ghrita: In this group, the first 5 days external oleation (Snehapana) with swedana (Patra Pinda Sweda) for 30-40 minutes. Matra basti for the next 12

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The age group of 2 to 16 years of either gender. 2. Previously Diagnosed Case of Cerebral palsy. 3. Children suffering from any types of CP due to different etiology. 4. If the participant history of epilepsy well controlled by medication. 5. If the patient has a Mild to Moderate intellectual disability. 5. Parents of CP children have given consent for the participation of their kids in the clinical trial during the study.

Exclusion criteria

Exclusion criteria: 1. Progressive neurological disorder. 2. Children suffering from any systemic illness, Children with severe intractable epilepsy as comorbidity, Congenital disorders like Down’s syndrome, Fragile -X syndrome or any congenital, infective disorder, myopathies of genetic origin, severe anaemia, metabolic and endocrinal disorders. 3. Acute illness that would interfere with carrying out the interventions. 4. Recent orthopedic surgery/ casting/ splint, Fixed contractures. 5. Children had received botox (last 1yr) or had undergone phenol block injection or intrathecal baclofen medication. 6. children have a severe intellectual disability. 5. Caregiver not willing to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
1. Lower down/Reduction the spasticity (Modified Ashworth Scale) 2. Improvement in range of motion (ROM) (Extendable goniometers) 3. Increase in muscle power (MRC Scale) 4. Gross motor milestone improvementTimepoint: 2-3 weeks

Secondary

MeasureTime frame
1. Lower down/Reduction the spasticity (Modified Ashworth Scale) 2. Improvement in range of motion (ROM) (Extendable goniometers) 3. Increase in muscle power 4. All Milestones improvement 5. Improvement in the quality of life (QOL)Timepoint: 6-7 weeks

Countries

India

Contacts

Public ContactDr Himanshu Chouhan

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

drppvyas@gmail.com9660057022

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026